{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-001328","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.150341+00:00","generated_at":"2026-06-18T11:25:06.936053+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cosmos Health issues €4.1M secured note to Cana Holdings; acquisition planned by March 31, 2023","bullets":["Cosmos Health issued a €4.1M secured promissory note to Cana Holdings, bearing interest at 5% + 1-month LIBOR, maturing in 5 years.","Note is secured by share pledges over all shares of Cana Holdings and its subsidiary Cana Pharmaceutical.","This is the first step of a two-step transaction; the second step is acquisition of all Cana Holdings shares by Cosmos Health by March 31, 2023.","Proceeds may not be used for capitalization or debt repayment without Cosmos Health's consent.","Cross-default provision: a default under any other financial instrument causing Material Adverse Effect can trigger default under this note."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-001328","json":"https://secwatch.observer/filing/0001477932-23-001328.json","markdown":"https://secwatch.observer/filing/0001477932-23-001328.md","text":"https://secwatch.observer/filing/0001477932-23-001328.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223001328/0001477932-23-001328-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223001328/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T11:25:06.936053+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fc50ee8549d8205576798b3fbee15eb38e66282f","claim":"Cosmos Health Inc. entered into Secured Promissory Note with Cana Laboratories Holdings (Cyprus) Limited valued at 5,000,000 EUR (effective 2023-02-28).","evidence_excerpt":"On February 28, 2023, Cosmos Health Inc. (the “Company”) was issued a five-year secured promissory note (the “Note”) in the principal amount of 4,100,000.00 EUR by Cana Laboratories Holdings (Cyprus) Limited, a corporation organized under the laws of the Republic of Cyprus (“Cana Holdings”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223001328/0001477932-23-001328-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Cana Laboratories Holdings (Cyprus) Limited"},{"label":"Value","value":"5,000,000 EUR"},{"label":"Effective","value":"2023-02-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}